Status:
UNKNOWN
Investigation of Human Alpha-fetoprotein Genes
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Elevated or Normal Alpha-fetoprotein Patients
Eligibility:
All Genders
20+ years
Brief Summary
Studies revealed that patients with hereditary persistence of AFP also had persistent abnormal AFP. Therefore, this study will recruit the patients and their family with elevated AFP (\>20 ng/mL) and ...
Detailed Description
Abnormal AFP elevation was usually noted in liver regeneration, HCC, nonseminomatous germ cell tumors or other malignant tumors. However, some studies revealed that patients with hereditary persistenc...
Eligibility Criteria
Inclusion
- The patients and their family with elevated AFP (\>20 ng/mL) and normal AFP patients being control groups. More than 20 years old
Exclusion
- Pregnancy
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2013
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01258894
Start Date
December 1 2010
End Date
October 1 2013
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100